Danske Bank A S decreased its stake in CVS Health Corporation (NYSE:CVS – Free Report) by 4.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 848,585 shares of the pharmacy operator’s stock after selling 41,914 shares during the period. Danske Bank A S’s holdings in CVS Health were worth $72,715,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in CVS Health in the second quarter valued at about $12,747,462,000. State Street Corp lifted its position in shares of CVS Health by 26.3% during the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock valued at $7,751,205,000 after acquiring an additional 15,604,883 shares during the period. Wellington Management Group LLP lifted its position in shares of CVS Health by 49.8% during the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after acquiring an additional 11,233,381 shares during the period. Bank of America Corp DE boosted its stake in shares of CVS Health by 148.0% during the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after acquiring an additional 13,836,701 shares in the last quarter. Finally, Pzena Investment Management LLC purchased a new stake in shares of CVS Health during the 2nd quarter worth approximately $1,217,558,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.
CVS Health Stock Performance
Shares of CVS opened at $89.37 on Monday. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68. The stock has a market cap of $114.34 billion, a P/E ratio of 10.40, a PEG ratio of 0.78 and a beta of 0.58. The company has a current ratio of 0.85, a quick ratio of 0.66 and a debt-to-equity ratio of 0.71. The company has a 50-day moving average of $89.65 and a two-hundred day moving average of $89.09.
CVS Health (NYSE:CVS – Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, beating the consensus estimate of $1.65 by $0.44. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The business had revenue of $108.40 billion for the quarter, compared to analyst estimates of $104.72 billion. During the same period in the prior year, the business earned $1.60 earnings per share. The company’s quarterly revenue was up 5.4% on a year-over-year basis. As a group, research analysts predict that CVS Health Corporation will post 8.26 EPS for the current fiscal year.
CVS Health Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were paid a $0.6650 dividend. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.0%. CVS Health’s dividend payout ratio is presently 30.97%.
Insider Transactions at CVS Health
In related news, EVP Prem Shah bought 23,855 shares of the stock in a transaction on Friday, November 6th. The shares were purchased at an average price of $83.89 per share, for a total transaction of $2,001,195.95. Following the acquisition, the executive vice president owned 88,516 shares in the company, valued at $7,425,607.24. This represents a 36.89% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.85% of the company’s stock.
Recent CVS Health Headlines
These are some of the CVS headlines that stood out recently:
- Positive Sentiment: A separation could give the pharmacy business and CVS’s other operations sharper strategic focus and improve capital allocation. Some analysts see potential for the pieces to be worth more separately, though the plan is not expected until 2028. CVS Breakup Won’t Satisfy Washington. It Could Still Work for Wall Street.
- Negative Sentiment: The separation may not ease political criticism: lawmakers and critics argue that retaining CVS’s other lucrative businesses, including its pharmacy-benefit operations, would leave key drug-pricing concerns unresolved. CVS is planning a huge corporate breakup after drug price criticism
- Negative Sentiment: Carving out the retail pharmacies could involve significant execution costs and operational risks, leaving uncertainty about whether the restructuring will deliver the anticipated value. Can CVS Health’s 2028 Split Unlock Value Despite Execution Risks?
Wall Street Analysts Forecast Growth
A number of research firms recently weighed in on CVS. Piper Sandler set a $106.00 price target on CVS Health in a report on Friday. Jefferies Financial Group reaffirmed a “buy” rating and set a $103.00 price objective on shares of CVS Health in a report on Wednesday, November 4th. TD Cowen reiterated a “buy” rating on shares of CVS Health in a research report on Wednesday, November 4th. JPMorgan Chase & Co. upped their target price on CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Finally, Argus raised their price target on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research report on Wednesday, August 19th. Twenty-three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $107.54.
Check Out Our Latest Research Report on CVS Health
CVS Health Profile
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
See Also
- Five stocks we like better than CVS Health
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
